Teva Pharmaceutical Industries ADR (TEVA)
$12.90
0.12 (0.94%)
TEVA Stock Quote Delayed 30 Minutes
TEVA Stock Pops 4% as Teva Receives FDA Approval
Teva Pharmaceutical stock is rising higher on Monday after partner company Alvotech got approval from the FDA for a Humira biosimilar.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
14.32B
PE Ratio
-92.14
EPS
-0.14
Volume (Avg. Vol.)
5.97M
Day's Range
$12.51 - $13.01
52-Week Range
$7.40 - $14.47
Dividend & Yield
N/A (N/A)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries ADR News
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO.
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.
Teva Stock Was a Good Buy Last Fall, but It Topped out After This Rally
TEVA stock was a great contrarian play last fall. With opioid liabilities hanging like an anvil over the company, shares were priced for disaster. More than doubling from their 2019 lows, I wouldn't say Teva shares are now "priced to perfection". But, the current share price may be pricing in much of the upside. Bottom Line? Consider TEVA stock a hold. With markets facing volatility, a better entry point could spring up down the road.
